At the present time, 430 drugs are known to cause respiratory injury. This represents an increase of almost 200 in the last ten years, and the number is still increasing. This comprehensive, definitive reference work, with an outstanding range of international expert contributors and two of the world's leading editors, provides an essential reference for the practising respiratory physician.The text builds upon basics with a review of basic sciences.
The book covers imaging, varied drug-induced interstitial lung disease including pulmonary edema and diffuse alveolar hemorrhage, acute respiratory failure, pleural involvement and upper to lower airway disease
A wide range of diseases are detailed from chemotherapy and radiation to biologic-induced lung disease, drug misuse, and special groups such as recipients of stem cell and solid organ transplants.
A range of world class contributions from key opinion leaders.
This book provides essential information for recognizing and managing drug-induced respiratory disease for all pulmonologists and respiratory care physicians. It will be of great interest to: critical care medicine specialists, hematologists, oncologists, cardiologists, allergists, rheumatologists, neurologists, internists, blood-bank specialists, pathologists and primary care physicians.
Classification, diagnosis, and management of drug-induced respiratory disease
Mechanisms of chemically induced respiratory toxicities
Imaging of drug-induced lung disease
Bronchoalveolar lavage in drug-induced lung disease
Pathology of drug-induced respiratory disease
Drug allergy in lung disease
DRUG-INDUCED RESPIRATORY EMERGENCIES
Drug-induced upper airway obstruction
Drug-induced pulmonary oedema and acute respiratory distress syndrome
Pulmonary complications of blood transfusion
Drug-induced alveolar haemorrhage
Pulmonary complications of illicit drug use
Iatrogenic tracheobronchial and chest injury
ONCOLOGY AND ALLIED CONDITIONS
Pulmonary reactions to chemotherapeutic agents: The 'chemotherapy lung'
Pulmonary reactions to novel chemotherapeutic agents and biomolecules
Radiation-induced lung disease
Pulmonary complications of bone-marrow and stem-cell transplantation
Pulmonary complications of solid-organ transplantation
Pulmonary infection induced by drugs
Pneumonitis induced by non-cytotoxic agents
Amiodarone pulmonary toxicity
Eosinophilic pneumonia induced by drugs
Bronchiolitis obliterans organizing pneumonia induced by drugs or radiotherapy
Coughing induced by drugs
Pleural disease induced by drugs
Lupus erythematosus syndrome induced by drugs
Vasculitis induced by drugs
Pulmonary hypertension induced by drugs and toxins
Respiratory involvement from herbals